FDA approves Luye Pharma’s ERZOFRI for schizophrenia
The US FDA has granted approval for Luye Pharma’s ERZOFRI extended-release injectable suspension for schizophrenia in adults.
The US FDA has granted approval for Luye Pharma’s ERZOFRI extended-release injectable suspension for schizophrenia in adults.
What's Your Reaction?
